144 related articles for article (PubMed ID: 35245567)
1. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study.
Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA
J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567
[No Abstract] [Full Text] [Related]
2. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.
Du ZF; Xu CM; Zhao Y; Liu WT; Chen XL; Chen CY; Fang H; Ke HP; Zhang XN
Eur J Dermatol; 2012; 22(4):476-80. PubMed ID: 22668561
[TBL] [Abstract][Full Text] [Related]
3. A novel frameshift mutation in keratin 16 underlies pachyonychia congenita with focal palmoplantar keratoderma.
Cao LH; Luo Y; Wen W; Liu WL; Jiang L; Chen C; Ji CY; Zhang X
Br J Dermatol; 2011 Nov; 165(5):1145-7. PubMed ID: 21668426
[No Abstract] [Full Text] [Related]
4. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
[TBL] [Abstract][Full Text] [Related]
5. [Keratin k6c mutations in focal palmoplantar keratoderma].
Dereure O
Ann Dermatol Venereol; 2010 May; 137(5):423-4. PubMed ID: 20470930
[No Abstract] [Full Text] [Related]
6. A large mutational study in pachyonychia congenita.
Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
[TBL] [Abstract][Full Text] [Related]
7. Thick nails, plantar keratoderma, follicular hyperkeratosis, and leukokeratosis associated with a novel mutation in KRT6A gene.
Tous-Romero F; Vico-Alonso C; Calleja-Algarra A; Sánchez-Calvín MT; Palencia-Pérez S
Int J Dermatol; 2019 Apr; 58(4):E89-E90. PubMed ID: 30515758
[No Abstract] [Full Text] [Related]
8. Mutations in a keratin 6 isomer (K6c) cause a type of focal palmoplantar keratoderma.
Bowden PE
J Invest Dermatol; 2010 Feb; 130(2):336-8. PubMed ID: 20081885
[TBL] [Abstract][Full Text] [Related]
9. A new KRT16 mutation associated with a phenotype of pachyonychia congenita.
Paris F; Hurtado C; Azón A; Aguado L; Vizmanos JL
Exp Dermatol; 2013 Dec; 22(12):838-9. PubMed ID: 24118415
[TBL] [Abstract][Full Text] [Related]
10. Pachyonychia congenita: a case report.
Kohli N
Cutis; 2009 Nov; 84(5):269-71. PubMed ID: 20099620
[TBL] [Abstract][Full Text] [Related]
11. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
Wu TT; Eldirany SA; Bunick CG; Teng JMC
J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
[TBL] [Abstract][Full Text] [Related]
12. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
13. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
Lessard JC; Coulombe PA
J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
[TBL] [Abstract][Full Text] [Related]
14. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.
Liao H; Sayers JM; Wilson NJ; Irvine AD; Mellerio JE; Baselga E; Bayliss SJ; Uliana V; Fimiani M; Lane EB; McLean WH; Leachman SA; Smith FJ
J Dermatol Sci; 2007 Dec; 48(3):199-205. PubMed ID: 17719747
[TBL] [Abstract][Full Text] [Related]
15. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
[TBL] [Abstract][Full Text] [Related]
16. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
Samuelov L; Smith FJD; Hansen CD; Sprecher E
Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
[TBL] [Abstract][Full Text] [Related]
17. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
[TBL] [Abstract][Full Text] [Related]
18. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.
Fu T; Leachman SA; Wilson NJ; Smith FJ; Schwartz ME; Tang JY
J Invest Dermatol; 2011 May; 131(5):1025-8. PubMed ID: 21160496
[TBL] [Abstract][Full Text] [Related]
20. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
